Evidence map›Paper›PMID 26006086›Full record

ArticleVaccine2015

Genetic stability of pneumococcal isolates during 35 days of human experimental carriage.

R A Gladstone, J F Gritzfeld, P Coupland, S B Gordon, S D Bentley

Abstract read
In one paragraph

Article in Vaccine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

R A GladstonePathogen Genomics, Wellcome Trust Sanger Institute, Cambridge, UK.
J F GritzfeldRespiratory Infection Group, Liverpool School of Tropical Medicine, Liverpool, UK.
P CouplandSequencing R&D Group, Wellcome Trust Sanger Institute, Cambridge, UK.
S B GordonRespiratory Infection Group, Liverpool School of Tropical Medicine, Liverpool, UK.
S D BentleyPathogen Genomics, Wellcome Trust Sanger Institute, Cambridge, UK. Electronic address: sdb@sanger.ac.uk.

Funding

Medical Research Council MR/M011569/1Wellcome TrustWellcome Trust 098051
6 · The paper itself

Abstract

backgroundPneumococcal carriage is a reservoir for transmission and a precursor to pneumococcal disease. The experimental human pneumococcal carriage model provides a useful tool to aid vaccine licensure through the measurement of vaccine efficacy against carriage (VEcol). Documentation of the genetic stability of the experimental human pneumococcal carriage model is important to further strengthen confidence in its safety and conclusions, enabling it to further facilitate vaccine licensure through providing evidence of VEcol.

methods229 isolates were sequenced from 10 volunteers in whom experimental human pneumococcal carriage was established, sampled over a period of 35 days. Multiple isolates from within a single volunteer at a single time provided a deep resolution for detecting variation. HiSeq data from the isolates were mapped against a PacBio reference of the inoculum to call variable sites.

resultsThe observed variation between experimental carriage isolates was minimal with the maximum SNP distance between any isolate and the reference being 3 SNPs.

conclusionThe low-level variation described provides evidence for the stability of the experimental human pneumococcal carriage model over 35 days, which can be reliably and confidently used to measure VEcol and aid future progression of pneumococcal vaccination.

Indexed as

Genetic VariationAdolescentAdultCarrier StateDNA, BacterialGenotypeHealthy VolunteersHumansMiddle AgedPneumococcal InfectionsPolymorphism, Single NucleotideSequence Analysis, DNAStreptococcus pneumoniaeYoung AdultDNA, BacterialExperimental human pneumococcal carriagePneumococcal vaccinesStreptococcus pneumoniaeVaccine efficacy against carriage (VEcol)

Identifiers

PMID26006086
PMCPMC4503797

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.